XPONANCE, INC. - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 249 filers reported holding MIRATI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.

Quarter-by-quarter ownership
XPONANCE, INC. ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$342,000
-40.4%
4,162
+6.4%
0.01%
-33.3%
Q4 2021$574,000
-13.8%
3,912
+4.0%
0.01%
-30.8%
Q3 2021$666,000
+7.8%
3,762
-1.7%
0.01%
+18.2%
Q2 2021$618,000
+131.5%
3,829
+215.4%
0.01%
+83.3%
Q4 2020$267,0001,2140.01%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 1,000,000$31,470,0008.67%
Baker Brothers Advisors 2,805,074$88,276,0000.77%
Broadfin Capital, LLC 359,661$11,319,0000.61%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 397,660$12,514,0000.42%
Boulegeris Investments, Inc. 17,415$548,0000.39%
SPHERA FUNDS MANAGEMENT LTD. 95,000$2,990,0000.29%
Rhenman & Partners Asset Management AB 50,000$1,574,0000.19%
Integre Asset Management, LLC 23,996$755,0000.16%
Orbimed Advisors 680,500$21,415,0000.16%
EAM Investors, LLC 38,754$1,220,0000.14%
View complete list of MIRATI THERAPEUTICS INC shareholders